Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CBIOCRESCENT BIOPHARMA, INC.

Nasdaq · CIK 0001253689
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts317

Identity from submissions API

NameCRESCENT BIOPHARMA, INC.
CIK0001253689
TickersCBIO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone617-430-5595
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • GLYCOMIMETICS INC (2003-07-10T04:00:00.000Z → 2025-06-23T04:00:00.000Z)
Business address
300 FIFTH AVENUE
WALTHAM
MA
02451
MA
Mailing address
300 FIFTH AVENUE
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

682 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000090 005-87811 261563143 34 18382
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004580 005-87811 261561362 34 10868
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003172 005-87811 261560782 34 25414
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005039 005-87811 261555043 34 15288
2026-11-12 8-K 8-K 2.02,9.01 0001628280-26-073409 001-36177 261547164 34 321428 1 1
2026-11-12 10-Q 10-Q 0001628280-26-073389 001-36177 261547057 34 8798959 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003736 005-87811 261491586 34 10801
2026-10-15 8-K 8-K 8.01 0001628280-26-066006 001-36177 261463359 34 157412 1 1
2026-09-18 4 FORM 4 0001628280-26-062709 5860
2026-09-18 4 FORM 4 0001628280-26-062707 5779
2026-09-18 4 FORM 4 0001628280-26-062706 5809
2026-09-18 4 FORM 4 0001628280-26-062705 5812
2026-09-18 4 FORM 4 0001628280-26-062703 5815
2026-09-18 4 FORM 4 0001628280-26-062701 17576
2026-09-18 4 FORM 4 0001628280-26-062700 17251
2026-09-18 S-8 S-8 0001628280-26-062634 333-299009 261389590 33 236165 1 1
2026-09-17 144 xsl144X01/primary_doc.xml 0001628280-26-062529 001-36177 261387305 33 6224
2026-09-17 144 xsl144X01/primary_doc.xml 0001628280-26-062526 001-36177 261387291 33 6153
2026-09-16 144 xsl144X01/primary_doc.xml 0001628280-26-062213 001-36177 261383460 33 15432
2026-09-16 144 xsl144X01/primary_doc.xml 0001628280-26-062211 001-36177 261383459 33 15818
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003420 005-87811 261275791 34 15232
2026-07-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002504 333-292600 261230193 33 1809
2026-07-30 POS AM POS AM 0001628280-26-050885 333-292600 261220570 33 386231
2026-07-30 424B3 424B3 0001628280-26-050881 333-292600 261220557 33 1409310
2026-07-30 10-Q 10-Q 0001628280-26-050869 001-36177 261220509 34 8681352 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001628280-26-050805 001-36177 261220212 34 321896 1 1
2026-07-20 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-085114 005-87811 261187623 34 22593
2026-07-20 4 OWNERSHIP DOCUMENT 0001104659-26-085113 13581
2026-07-15 8-K 8-K 8.01,9.01 0001628280-26-048347 001-36177 261177934 34 952418 1 1
2026-07-15 424B5 424B5 0001628280-26-048344 333-297199 261177923 33 594064
2026-07-14 8-K 8-K 2.02 0001628280-26-048151 001-36177 261174325 34 142295 1 1
2026-07-14 424B5 424B5 0001628280-26-048144 333-297199 261174271 33 581250
2026-07-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002258 333-297199 261169841 33 1796
2026-07-01 S-3 S-3 0001628280-26-046544 333-297199 261145333 33 1681595 1 1
2026-06-23 4 FORM 4 0001628280-26-044893 5855
2026-06-23 4 FORM 4 0001628280-26-044892 5775
2026-06-23 4 FORM 4 0001628280-26-044890 5808
2026-06-23 4 FORM 4 0001628280-26-044887 5811
2026-06-23 4 FORM 4 0001628280-26-044886 5805
2026-06-23 4 FORM 4 0001628280-26-044885 5846
2026-06-23 4 FORM 4 0001628280-26-044884 5854
2026-06-22 424B3 424B3 0001628280-26-044718 333-292600 261107988 33 128123
2026-06-22 10-Q/A 10-Q/A 0001628280-26-044713 001-36177 261107962 34 531414 1 1
2026-06-03 4 FORM 4 0001628280-26-040583 5720
2026-06-03 4 FORM 4 0001628280-26-040582 5762
2026-06-03 4 FORM 4 0001628280-26-040580 5695
2026-06-03 4 FORM 4 0001628280-26-040577 5675
2026-06-03 4 FORM 4 0001628280-26-040575 12008
2026-06-03 8-K 8-K 5.07 0001628280-26-040051 001-36177 261059145 34 156847 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-006496 005-87811 26987674 34 14392
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225181 005-87811 26982018 34 141561
2026-04-29 424B3 424B3 0001628280-26-028415 333-292600 26916635 33 1163983
2026-04-29 8-K 8-K 2.02,9.01 0001628280-26-028386 001-36177 26916246 34 297453 1 1
2026-04-29 10-Q 10-Q 0001628280-26-028362 001-36177 26915881 34 7468112 1 1
2026-04-21 DEFA14A DEFA14A 0001628280-26-026291 001-36177 26879702 34 1125105
2026-04-21 DEFA14A DEFA14A 0001628280-26-026285 001-36177 26879637 34 1272501
2026-04-21 DEF 14A DEF 14A 0001628280-26-026282 001-36177 26879607 34 7282656 1 1
2026-03-17 424B3 424B3 0001628280-26-018693 333-292600 26761617 33 18533624
2026-03-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000704 333-292600 26718703 33 1808
2026-03-03 POS AM POS AM 0001628280-26-013540 333-292600 26710828 33 18713015
2026-02-26 424B3 424B3 0001628280-26-012015 333-292600 26681995 33 18377349
2026-02-26 S-8 S-8 0001628280-26-011991 333-293771 26681720 33 245883 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001628280-26-011988 001-36177 26681707 34 319986 1 1
2026-02-26 10-K 10-K 0001628280-26-011983 001-36177 26681704 34 42073429 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001738048-26-000018 005-87811 26644082 34 18065
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001077 005-87811 26640988 34 16368
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000413 005-87811 26601865 34 11510
2026-01-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000182 333-292600 26537557 33 1795
2026-01-15 424B3 424B3 0001628280-26-002218 333-292600 26536925 33 12298872
2026-01-13 CORRESP filename1.htm 0001628280-26-001951 8836
2026-01-12 UPLOAD filename1.pdf 0000000000-26-000353 333-292600 40108
2026-01-07 S-1 S-1 0001628280-26-001227 333-292600 26516509 33 35454020 1 1
2025-12-17 4 FORM 4 0001628280-25-057687 8866
2025-12-17 4 FORM 4 0001628280-25-057685 8938
2025-12-17 4 FORM 4 0001628280-25-057683 8930
2025-12-17 4 FORM 4 0001628280-25-057681 8898
2025-12-17 4 FORM 4 0001628280-25-057678 8918
2025-12-17 4 FORM 4 0001628280-25-057673 8911
2025-12-17 4 FORM 4 0001628280-25-057671 8979
2025-12-17 4 FORM 4 0001628280-25-057669 8917
2025-12-12 S-4 POS S-4 POS 0001628280-25-056652 333-285035 251566577 33 9886751 1 1
2025-12-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-315863 005-87811 251564850 34 12237
2025-12-10 4 FORM 4 0001628280-25-056333 5498
2025-12-10 4 FORM 4 0001628280-25-056331 5506
2025-12-08 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-119323 005-87811 251556467 34 29603
2025-12-08 4 OWNERSHIP DOCUMENT 0001104659-25-119320 13232
2025-12-04 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001628280-25-055221 001-36177 251548297 34 10077193 1 1
2025-11-06 S-8 S-8 0001628280-25-049876 333-291307 251456213 33 432689 1 1
2025-11-06 8-A12B/A 8-A12B/A 0001628280-25-049873 001-36177 251456194 34 77730
2025-11-06 10-Q 10-Q 0001628280-25-049868 001-36177 251456182 34 8001844 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001628280-25-049865 001-36177 251456162 34 286103 1 1
2025-10-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-014932 005-87811 251391585 34 9878
2025-10-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-014813 005-87811 251385231 34 26168
2025-08-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-012492 005-87811 251237763 34 9756
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-002280 005-87811 251218457 34 24805
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000528 005-87811 251217515 34 20227
2025-07-31 8-K 8-K 2.02,5.02,9.01 0001628280-25-036846 001-36177 251169449 34 405909 1 1
2025-07-31 10-Q 10-Q 0001628280-25-036839 001-36177 251169421 34 7157429 1 1
2025-07-16 4 OWNERSHIP DOCUMENT 0001104659-25-068426 5575
2025-07-15 3 OWNERSHIP DOCUMENT 0001104659-25-068102 9919
2025-07-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001679 005-87811 251109658 34 11385
2025-06-30 3 OWNERSHIP DOCUMENT 0001104659-25-064138 12956
2025-06-30 3 OWNERSHIP DOCUMENT 0001104659-25-064118 13010
2025-06-23 4 OWNERSHIP DOCUMENT 0001104659-25-061820 5508
2025-06-23 4 OWNERSHIP DOCUMENT 0001104659-25-061819 11586
2025-06-23 4 OWNERSHIP DOCUMENT 0001104659-25-061818 5553
2025-06-23 4 OWNERSHIP DOCUMENT 0001104659-25-061817 5528
2025-06-23 4 OWNERSHIP DOCUMENT 0001104659-25-061816 5595
2025-06-23 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-061806 005-87811 251066222 34 40074
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061801 13022
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061800 14867
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061799 12897
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061796 14530
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061794 14519
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061793 23011
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061792 12923
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061791 14353
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061789 12867
2025-06-23 3 OWNERSHIP DOCUMENT 0001104659-25-061788 13070
2025-06-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-017961 005-87811 251065296 34 35634
2025-06-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-25-002765 005-87811 251061305 34 10626
2025-06-18 8-K FORM 8-K 1.01,2.01,2.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01 0001104659-25-060714 001-36177 251057953 34 2613283 1 1
2025-06-17 4 OWNERSHIP DOCUMENT 0000921895-25-001784 35494
2025-06-06 8-K FORM 8-K 5.07,7.01,8.01,9.01 0001104659-25-057078 001-36177 251028962 34 267782 1 1
2025-05-30 425 425 0001104659-25-054588 001-36177 251006654 34 402819
2025-05-30 8-K FORM 8-K 8.01 0001104659-25-054587 001-36177 251006649 34 600414 1 1
2025-05-29 425 425 0001104659-25-053921 001-36177 25997837 34 26069
2025-05-14 SEC STAFF LETTER filename1.pdf 9999999997-25-002358 65226
2025-05-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001591 333-285035 25948310 33 1709
2025-05-14 10-Q 10-Q 0001558370-25-007780 001-36177 25946971 34 3914250 1 1
2025-05-14 424B3 424B3 0001104659-25-048564 333-285035 25946512 33 10051573
2025-05-13 CORRESP filename1.htm 0001104659-25-047721 8359
2025-05-12 CORRESP filename1.htm 0001104659-25-047014 19475
2025-05-12 S-4/A S-4/A 0001104659-25-047011 333-285035 25932569 33 10329907
2025-05-08 UPLOAD filename1.pdf 0000000000-25-004934 333-285035 43903
2025-04-29 S-4/A S-4/A 0001104659-25-040398 333-285035 25882281 33 10430215
2025-04-29 425 425 0001104659-25-040389 001-36177 25882259 34 160179
2025-04-29 8-K FORM 8-K 1.01,9.01 0001104659-25-040386 001-36177 25882256 34 365242 1 1
2025-04-28 CORRESP filename1.htm 0001104659-25-040399 60337
2025-04-28 425 425 0001104659-25-039786 001-36177 25875992 34 34584
2025-04-22 UPLOAD filename1.pdf 0000000000-25-004254 333-285035 63982
2025-04-04 CORRESP filename1.htm 0001104659-25-032134 73466
2025-04-04 CORRESP filename1.htm 0001104659-25-032132 116953
2025-04-04 S-4/A FORM S-4/A 0001104659-25-032130 333-285035 25812905 33 9708757
2025-04-03 425 425 0001104659-25-031462 001-36177 25807516 34 53854
2025-04-03 425 425 0001104659-25-031461 001-36177 25807515 34 5846543
2025-03-18 SEC STAFF LETTER filename1.pdf 9999999997-25-001553 64778
2025-03-17 UPLOAD filename1.pdf 0000000000-25-002902 333-285035 89884
2025-02-28 425 425 0001558370-25-001956 001-36177 25691962 34 6067797
2025-02-27 425 425 0001104659-25-017675 001-36177 25672562 34 41774
2025-02-25 425 425 0001558370-25-001518 001-36177 25664566 34 43769
2025-02-25 8-K 8-K 1.02,5.02 0001558370-25-001517 001-36177 25664548 34 170970 1 1
2025-02-18 S-4 FORM-S-4 0001104659-25-014838 333-285035 25636100 33 16530247 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004289 005-87811 25631720 34 17027
2025-02-14 425 425 0001558370-25-001017 001-36177 25629912 34 634166
2025-02-14 8-K 8-K 1.01,9.01 0001558370-25-001016 001-36177 25629890 34 871367 1 1
2025-02-13 10-K 10-K 0001558370-25-000948 001-36177 25620795 34 7257730 1 1
2025-01-31 8-K 8-K 5.02 0001558370-25-000576 001-36177 25579234 34 155105 1 1
2025-01-13 DEFA14A DEFA14A 0001104659-25-002895 001-36177 25525045 34 7380451
2025-01-13 8-K FORM 8-K 7.01,9.01 0001104659-25-002893 001-36177 25525040 34 7575094 1 1
2024-12-26 8-K 8-K 3.01 0001558370-24-016472 001-36177 241581389 34 158334 1 1
2024-11-27 SC 13G glyc13g.htm 0000935836-24-000745 005-87811 241509952 34 60919
2024-11-13 10-Q 10-Q 0001558370-24-015537 001-36177 241454881 34 5793608 1 1
2024-11-12 SC 13G/A SC 13G/A 0001193125-24-256013 005-87811 241448883 34 94594
2024-11-07 DEFA14A DEFA14A 0001104659-24-115361 001-36177 241436717 34 4467250
2024-11-07 8-K FORM 8-K 7.01,9.01 0001104659-24-115355 001-36177 241436642 34 4661193 1 1
2024-11-06 SC 13G SC 13G 0001104659-24-114867 005-87811 241432416 34 96192
2024-11-04 SC 13D GLYCOMIMETICS INC 0000902664-24-006210 005-87811 241423962 34 87023
2024-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002033801-24-000003 005-87811 241422528 34 6179
2024-10-29 DEFA14A DEFA14A 0001104659-24-112055 001-36177 241402747 34 7895176
2024-10-29 8-K FORM 8-K 1.01,3.02,5.01,5.02,7.01,8.01,9.01 0001104659-24-112054 001-36177 241402744 34 8432112 1 1
2024-08-15 SC 13G/A SC 13G/A 0001193125-24-201382 005-87811 241213270 34 92080
2024-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002033801-24-000002 005-87811 241207917 34 6062
2024-08-09 4 4 0000950170-24-094800 15003
2024-08-08 10-Q 10-Q 0001558370-24-011579 001-36177 241188012 34 5344472 1 1
2024-08-07 4 4 0000950170-24-092864 14946
2024-08-05 4 4 0000950170-24-090910 14946
2024-07-30 4 4 0000950170-24-088020 16920
2024-07-30 8-K 8-K 2.05,5.02,7.01,9.01 0001558370-24-010370 001-36177 241157198 34 210423 1 1
2024-07-29 SC 13G/A SC 13G/A 0001193125-24-187843 005-87811 241154017 34 191198
2024-07-29 3 3 0000950170-24-087411 8558
2024-06-26 8-K 8-K 3.01 0001558370-24-009508 001-36177 241073806 34 173464 1 1
2024-06-24 4 xslF345X05/form4-06242024_080643.xml 0001415889-24-017978 6942
2024-06-20 4 xslF345X05/form4-06202024_040634.xml 0001415889-24-017623 5046
2024-06-13 8-K 8-K 5.02 0001558370-24-009140 001-36177 241041660 34 182440 1 1
2024-06-04 8-K 8-K 7.01,9.01 0001558370-24-008882 001-36177 241016245 34 8585044 1 1
2024-05-09 10-Q 10-Q 0001558370-24-007632 001-36177 24931251 34 4855538 1 1
2024-05-08 SC 13D/A NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#4E) 0001072613-24-000441 005-87811 24927375 34 121062
2024-05-06 8-K 8-K 2.02,7.01,9.01 0001558370-24-006793 001-36177 24917384 34 7163597 1 1
2024-05-02 8-K 8-K 5.03,5.07,9.01 0001558370-24-006459 001-36177 24905479 34 320499 1 1
2024-05-01 4 xslF345X05/form4-05012024_080541.xml 0001415889-24-011872 5320
2024-05-01 4 xslF345X05/form4-05012024_080555.xml 0001415889-24-011869 5335
2024-05-01 4 xslF345X05/form4-05012024_080504.xml 0001415889-24-011867 5363
2024-05-01 4 xslF345X05/form4-05012024_080549.xml 0001415889-24-011863 5372
2024-05-01 4 xslF345X05/form4-05012024_080551.xml 0001415889-24-011862 5369
2024-05-01 4 xslF345X05/form4-05012024_080513.xml 0001415889-24-011861 5333
2024-05-01 4 xslF345X05/form4-05012024_080522.xml 0001415889-24-011860 5406
2024-04-02 4 xslF345X05/form4-04022024_040420.xml 0001415889-24-009745 4842
2024-04-02 4 xslF345X05/form4-04022024_040411.xml 0001415889-24-009743 7810
2024-04-02 4 xslF345X05/form4-04022024_040413.xml 0001415889-24-009744 5464
2024-04-01 ARS ARS 0001558370-24-004451 001-36177 24805717 34 4036299
2024-04-01 DEF 14A DEF 14A 0001558370-24-004448 001-36177 24805700 34 1547509
2024-03-27 S-8 S-8 0001558370-24-004078 333-278265 24790496 33 178205
2024-03-27 8-K 8-K 2.02,9.01 0001558370-24-004015 001-36177 24785985 34 427777 1 1
2024-03-27 10-K 10-K 0001558370-24-004013 001-36177 24785912 34 7123910 1 1
2024-03-22 PRE 14A PRE 14A 0001558370-24-003788 001-36177 24776054 34 1550559
2024-03-01 8-K 8-K 7.01,9.01 0001558370-24-002241 001-36177 24707236 34 7605692 1 1
2024-02-29 SC 13D/A NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#3) 0001072613-24-000287 005-87811 24706290 34 350972
2024-02-12 SC 13D/A NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#2) 0001072613-24-000125 005-87811 24620811 34 346529
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030255 005-87811 24615981 34 137575
2024-01-29 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0000921895-24-000153 005-87811 24574121 34 277948
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001742 5551
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001741 5578
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001740 5528
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001739 5542
2024-01-17 4 FORM 4 SUBMISSION 0001209191-24-001738 5578
2024-01-02 8-K 8-K 1.01 0001558370-24-000013 001-36177 24502871 34 157451 1 1
2024-01-02 4 FORM 4 SUBMISSION 0001209191-24-000069 4816
2024-01-02 4 FORM 4 SUBMISSION 0001209191-24-000068 7683
2024-01-02 4 FORM 4 SUBMISSION 0001209191-24-000067 5475
2023-11-03 8-K 8-K 2.02,9.01 0001558370-23-017507 001-36177 231374584 34 416493 1 1
2023-11-03 10-Q 10-Q 0001558370-23-017505 001-36177 231374580 34 5347516 1 1
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051449 5394
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051392 4735
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051390 7588
2023-09-25 4 FORM 4 SUBMISSION 0001209191-23-050476 6951
2023-08-02 8-K 8-K 2.02,9.01 0001558370-23-012816 001-36177 231133847 34 411692 1 1
2023-08-02 10-Q 10-Q 0001558370-23-012814 001-36177 231133831 34 5244083 1 1
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033675 6769
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031465 5299
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031462 5333
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031456 5247
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031454 5262
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031451 5290
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031446 5296
2023-05-22 4 FORM 4 SUBMISSION 0001209191-23-031443 5260
2023-05-22 8-K 8-K 5.07 0001558370-23-010301 001-36177 23944321 34 166978 1 1
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030636 4881
2023-05-17 144 xsl144X01/primary_doc.xml 0001971857-23-000128 001-36177 23930311 33 4081
2023-05-11 4 FORM 4 SUBMISSION 0001209191-23-028816 4515
2023-05-09 4 FORM 4 SUBMISSION 0001209191-23-028305 4514
2023-05-03 8-K 8-K 2.02,9.01 0001558370-23-007746 001-36177 23881865 34 273112 1 1
2023-05-03 10-Q 10-Q 0001558370-23-007744 001-36177 23881859 34 5512828 1 1
2023-04-21 8-K 8-K 1.01,9.01 0001558370-23-006434 001-36177 23836239 34 222275 1 1
2023-04-21 ARS ARS 0001558370-23-006405 001-36177 23835428 34 3450664
2023-04-21 DEF 14A DEF 14A 0001558370-23-006383 001-36177 23834651 34 1485968
2023-03-31 3 FORM 3 SUBMISSION 0001209191-23-021877 8690
2023-03-31 3 FORM 3 SUBMISSION 0001209191-23-021872 10505
2023-03-29 S-8 S-8 0001558370-23-004931 333-270941 23775620 33 182743
2023-03-29 8-K 8-K 2.02,9.01 0001558370-23-004866 001-36177 23771863 34 326593 1 1
2023-03-29 10-K 10-K 0001558370-23-004864 001-36177 23771858 34 6956794 1 1
2023-03-10 8-K 8-K 7.01 0001558370-23-003498 001-36177 23724606 34 154534 1 1
2023-03-02 8-K 8-K 7.01,9.01 0001558370-23-002692 001-36177 23699482 34 7308755 1 1
2023-02-28 4 FORM 4 SUBMISSION 0000899243-23-006426 17922
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006027 22204
2023-02-21 8-K 8-K 5.02 0001558370-23-001631 001-36177 23647963 34 157403 1 1
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005502 22734
2023-02-13 4 FORM 4 SUBMISSION 0000899243-23-004819 18451
2023-02-13 3 FORM 3 SUBMISSION 0000899243-23-004810 16948
2023-02-13 SC 13G SC 13G 0001193125-23-036093 005-87811 23619974 34 148762
2023-02-10 SC 13D/A NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#1) 0001072613-23-000059 005-87811 23613536 34 303416
2023-02-06 5 FORM 5 SUBMISSION 0001209191-23-007267 9355
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005471 6737
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005326 11811
2023-01-20 4 FORM 4 SUBMISSION 0001209191-23-004228 5464
2023-01-20 4 FORM 4 SUBMISSION 0001209191-23-004218 5464
2023-01-20 4 FORM 4 SUBMISSION 0001209191-23-004212 5414
2023-01-06 4 FORM 4 SUBMISSION 0001209191-23-002468 7854
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001186 15753
2022-12-27 4 FORM 4 SUBMISSION 0001209191-22-062741 4929
2022-11-18 4 FORM 4 SUBMISSION 0001209191-22-057823 4956
2022-11-16 4 FORM 4 SUBMISSION 0001209191-22-057314 6921
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056587 4441
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056581 4977
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056576 4977
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056573 5868
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056563 4505
2022-11-09 10-Q 10-Q 0001558370-22-017036 001-36177 221370783 34 5431651 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001558370-22-017028 001-36177 221370753 34 315408 1 1
2022-10-04 8-K 8-K 7.01,9.01 0001558370-22-014828 001-36177 221292807 34 4595245 1 1
2022-09-07 4 FORM 4 SUBMISSION 0001209191-22-048996 5427
2022-09-07 3 FORM 3 SUBMISSION 0001209191-22-048994 7477
2022-08-03 10-Q 10-Q 0001558370-22-011770 001-36177 221131039 34 5229291 1 1
2022-08-03 8-K 8-K 2.02,9.01 0001558370-22-011768 001-36177 221131028 34 431086 1 1
2022-06-03 8-K 8-K 3.01 0001558370-22-009711 001-36177 22994206 34 156493 1 1
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031010 5258
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031007 5215
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-030999 5267
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-030991 5301
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-030982 5228
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-030977 5230
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-030966 5264
2022-05-20 8-K FORM 8-K 5.02,5.07,9.01 0001104659-22-063262 001-36177 22946627 34 414637 1 1
2022-04-28 424B5 424B5 0001104659-22-052377 333-263297 22867791 33 141877
2022-04-28 10-Q 10-Q 0001558370-22-006260 001-36177 22866332 34 5120488 1 1
2022-04-28 8-K 8-K 2.02,9.01 0001558370-22-006206 001-36177 22862426 34 287415 1 1
2022-04-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-22 16:00:00 9999999995-22-001062 333-263297 22847215 33 1667
2022-04-20 CORRESP filename1.htm 0001104659-22-047819 18135
2022-04-11 DEF 14A DEF 14A 0001558370-22-005265 001-36177 22818538 34 1656618
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017977 6271
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017968 5380
2022-03-10 4 FORM 4 SUBMISSION 0001209191-22-017963 5380
2022-03-10 UPLOAD filename1.pdf 0000000000-22-002656 40092
2022-03-04 S-3 S-3 0001104659-22-030591 333-263297 22714066 33 1252335
2022-03-03 S-8 S-8 0001558370-22-002784 333-263257 22708547 33 183152
2022-03-03 8-K 8-K 2.02,9.01 0001558370-22-002741 001-36177 22706844 34 336839 1 1
2022-03-03 10-K 10-K 0001558370-22-002737 001-36177 22706823 34 7104718 1 1
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017652 005-87811 22609845 34 12905
2022-01-27 8-K 8-K 5.02,8.01 0001558370-22-000516 001-36177 22563556 34 156281 1 1
2022-01-25 4 FORM 4 SUBMISSION 0001209191-22-004896 8094
2022-01-25 4 FORM 4 SUBMISSION 0001209191-22-004893 8102
2022-01-25 4 FORM 4 SUBMISSION 0001209191-22-004882 8094
2022-01-25 4 FORM 4 SUBMISSION 0001209191-22-004880 5475
2021-11-18 4 FORM 4 SUBMISSION 0001209191-21-065434 4918
2021-11-02 10-Q 10-Q 0001558370-21-014003 001-36177 211369390 34 5529503 1 1
2021-11-02 8-K 8-K 2.02,9.01 0001558370-21-014000 001-36177 211369354 34 320983 1 1
2021-08-10 3 FORM 3 SUBMISSION 0001209191-21-050597 10389
2021-08-05 10-Q 10-Q 0001558370-21-010410 001-36177 211146444 34 5244482 1 1
2021-08-05 8-K 8-K 2.02,5.02,7.01,8.01,9.01 0001558370-21-010404 001-36177 211146393 34 383430 1 1
2021-07-12 SC 13G/A us38000q1022_071021.txt 0000834237-21-008686 005-87811 211084417 34 12184
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036384 7370
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036382 7296
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036380 7332
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036378 7991
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036376 7283
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036373 7326
2021-05-20 8-K 8-K 5.07 0001558370-21-007580 001-36177 21944391 34 167028 1 1
2021-05-03 8-K 8-K 2.02,9.01 0001558370-21-005478 001-36177 21881607 34 301271 1 1
2021-05-03 10-Q 10-Q 0001558370-21-005473 001-36177 21881513 34 4635766 1 1
2021-04-05 DEF 14A DEF 14A 0001558370-21-003956 001-36177 21803806 34 1005867
2021-03-08 3 FORM 3 SUBMISSION 0001209191-21-018539 12947
2021-03-02 S-8 S-8 0001558370-21-002264 333-253788 21704166 33 181384
2021-03-02 8-K 8-K 2.02,9.01 0001558370-21-002259 001-36177 21703802 34 350380 1 1
2021-03-02 10-K 10-K 0001558370-21-002222 001-36177 21701374 34 6867502 1 1
2021-02-23 8-K 8-K 5.02,7.01,9.01 0001558370-21-001475 001-36177 21665986 34 187138 1 1
2021-02-16 SC 13G/A PRIMARY DOCUMENT 0001654954-21-001679 005-87811 21632764 34 69063
2021-02-12 SC 13G/A glyc13ga.htm 0000935836-21-000103 005-87811 21626702 34 46637
2021-02-11 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-21-000334 005-87811 21620914 34 279592
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-018187 005-87811 21610863 34 13751
2021-01-29 SC 13G/A us38000q1022_012921.txt 0000834237-21-003995 005-87811 21568847 34 13083
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004850 7540
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004847 7540
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004845 7562
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004840 8431
2021-01-22 4 FORM 4 SUBMISSION 0001209191-21-004833 9481
2020-12-30 4 FORM 4 SUBMISSION 0001209191-20-065499 11589
2020-12-17 4 FORM 4 SUBMISSION 0001209191-20-064018 6797
2020-12-10 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000442 005-87811 201379523 34 32692
2020-11-06 4 OWNERSHIP DOCUMENT 0000921895-20-002828 26298
2020-11-06 8-K 8-K 2.02,9.01 0001558370-20-013033 001-36177 201292709 34 350153 1 1
2020-11-06 10-Q 10-Q 0001558370-20-013021 001-36177 201292461 34 5198054 1 1
2020-11-03 4 OWNERSHIP DOCUMENT 0000921895-20-002779 26354
2020-10-07 424B5 424B5 0001047469-20-005139 333-231577 201229554 33 163904
2020-10-07 8-K 8-K 1.01,9.01 0001558370-20-011405 001-36177 201229268 34 473508 1 1
2020-07-31 8-K 8-K 2.02,9.01 0001558370-20-008848 001-36177 201063912 34 350610 1 1
2020-07-31 10-Q 10-Q 0001558370-20-008841 001-36177 201063866 34 5114083 1 1
2020-07-20 SC 13G glyco13g.htm 0000935836-20-000390 005-87811 201036712 34 46778
2020-07-10 SC 13G/A SEC SCHEDULE 13G 0000914208-20-000361 005-87811 201023024 34 17936
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032315 5301
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032311 5258
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032308 5215
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032304 5228
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032302 5230
2020-05-27 4 FORM 4 SUBMISSION 0001209191-20-032299 5264
2020-05-26 8-K 8-K 5.07 0001558370-20-006971 001-36177 20911024 34 60426
2020-05-08 DEFA14A DEFA14A 0001558370-20-005890 001-36177 20858918 34 59380
2020-05-01 8-K 8-K 2.02,9.01 0001558370-20-004881 001-36177 20838573 34 192512
2020-05-01 10-Q 10-Q 0001558370-20-004879 001-36177 20838515 34 4168264 1
2020-04-16 DEF 14A DEF 14A 0001558370-20-003935 001-36177 20795248 34 1259913
2020-04-09 SC 13G/A SEC SCHEDULE 13G 0000914208-20-000283 005-87811 20783800 34 18051
2020-04-09 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000372 005-87811 20783266 34 37431
2020-03-10 4 FORM 4 SUBMISSION 0001209191-20-017836 4954
2020-02-28 S-8 S-8 0001558370-20-001772 333-236754 20669974 33 209875
2020-02-28 8-K 8-K 2.02,8.01,9.01 0001558370-20-001731 001-36177 20666703 34 243059
2020-02-28 10-K 10-K 0001558370-20-001723 001-36177 20665754 34 7946516 1
2020-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-20-000539 005-87811 20618542 34 289518
2020-02-14 SC 13G/A glyc13gadec19.txt 0000080255-20-001261 005-87811 34 6948
2020-02-10 8-K 8-K 1.02 0001558370-20-000636 001-36177 20591849 34 32096
2020-02-07 SC 13G/A SEC SCHEDULE 13G 0000914208-20-000058 005-87811 20587480 34 18161
2020-02-05 SC 13G/A us38000q1022_020420.txt 0000834237-20-005369 005-87811 20577314 34 13081
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004828 5460
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004826 5468
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004824 5460
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004818 5481
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004814 5460
2020-01-08 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000035 005-87811 20515550 34 37497
2020-01-07 8-K 8-K 1.01,7.01,9.01 0001558370-20-000060 001-36177 20513343 34 88487
2020-01-06 4 FORM 4 SUBMISSION 0001209191-20-002098 7811
2019-12-23 4 FORM 4 SUBMISSION 0001209191-19-061782 7817
2019-11-21 8-K 8-K 7.01 0001558370-19-011165 001-36177 191235638 34 30604
2019-11-07 8-K 8-K 2.02,9.01 0001558370-19-010292 001-36177 191198264 34 220671
2019-11-07 10-Q 10-Q 0001558370-19-010290 001-36177 191198242 34 4773627 1
2019-09-10 SC 13G/A filing.txt 0000315066-19-001702 005-87811 191084603 34 8361
2019-09-09 4 OWNERSHIP DOCUMENT 0000921895-19-002381 20652
2019-09-09 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-19-002380 005-87811 191083499 34 209344
2019-08-26 3 OWNERSHIP DOCUMENT 0000921895-19-002332 17902
2019-08-15 4 FORM 4 SUBMISSION 0001209191-19-046095 4484
2019-08-15 SC 13G SCHEDULE 13G 0000921895-19-002247 005-87811 191029512 34 220179
2019-08-15 SC 13G PRIMARY DOCUMENT 0001654954-19-009665 005-87811 191029397 34 69048
2019-08-12 SC 13G/A filing.txt 0000315066-19-001676 005-87811 191014721 34 8309

Latest XBRL company facts

One latest value per concept from companyfacts (317 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 38.90M 2026-11-11 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
dei EntityPublicFloat Entity Public Float USD 177.20M 2025-06-30 2025 FY 10-K 2026-02-26 0001628280-26-011983
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 6.38M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001628280-26-026282
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 5.13M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001628280-26-026282
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 17.58M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001628280-26-026282
ecd PeoTotalCompAmt PeoTotalCompAmt USD 13.12M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001628280-26-026282
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 3.91 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001628280-26-026282
ffd NetFeeAmt NetFeeAmt USD 1,882.99 2026-09-18 S-8 2026-09-18 0001628280-26-062634
ffd TtlFeeAmt TtlFeeAmt USD 1,882.99 2026-09-18 S-8 2026-09-18 0001628280-26-062634
ffd TtlOfferingAmt TtlOfferingAmt USD 13.63M 2026-09-18 S-8 2026-09-18 0001628280-26-062634
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-18 S-8 2026-09-18 0001628280-26-062634
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-16 S-3 2026-07-01 0001628280-26-046544
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 0.33 2014-04-13 2014-04-14 2014 Q3 10-Q 2014-10-31 0001193125-14-391030
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 264,329 2020-12-31 2021 FY 10-K 2022-03-03 0001558370-22-002737
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 104,671 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AccretionExpense Accretion Expense USD 19,200 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2.56M 2023-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 3,528 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 20,388 2015-03-31 2015 Q1 10-Q 2015-05-05 0001193125-15-172196
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 21.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.51M 2023-09-30 2023 Q3 10-Q 2023-11-03 0001558370-23-017505
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 527.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 126.97M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001558370-15-002591
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.22M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 5,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 13.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 423,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 205,899 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap Assets Assets USD 299.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AssetsCurrent Assets, Current USD 295.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 157.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap AssetsHeldForSaleLongLived Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) USD 0 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2023-12-31 2023 FY 10-K 2024-03-27 0001558370-24-004013
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2015-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap Cash Cash USD 152.65M 2025-06-30 2025 Q2 10-Q 2025-07-31 0001628280-25-036839
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 289.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 157.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 118.71M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001558370-18-003836
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 289.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 5.61M 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 76.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.33 2018-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002222
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 553,868 2018-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002222
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2018-09-30 2018 Q3 10-Q 2018-11-02 0001558370-18-008314
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 16.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 175.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 38.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 38.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CommonStockValue Common Stock, Value, Issued USD 38,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -85.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.08 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001558370-23-004864
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 387,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredRentCredit Deferred Rent Credit USD 732,387 2018-09-30 2018 Q3 10-Q 2018-11-02 0001558370-18-008314
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 98,771 2018-12-31 2019 FY 10-K 2020-02-28 0001558370-20-001723
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 611,623 2018-12-31 2019 FY 10-K 2020-02-28 0001558370-20-001723
us-gaap DeferredRentReceivablesNet Deferred Rent Receivables, Net USD 97,012 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 23.44M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 48.38M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 5.87M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 387,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 12.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 62.96M 2015-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1,303 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 5,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.42M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 6.70M 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.80M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 51,400 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 47.99M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 144,083 2022-12-31 2023 FY 10-K 2024-03-27 0001558370-24-004013
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 211,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 10,649 2016-12-31 2017 FY 10-K 2018-03-06 0001558370-18-001553
us-gaap Depreciation Depreciation USD 197,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 68.38M 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap DisposalGroupIncludingDiscontinuedOperationLongLivedAssets Disposal Group, Including Discontinued Operation, Long Lived Assets (Deprecated 2015-01-31) USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.04 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.9 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0001558370-21-014003
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.04 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.229 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.051 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.004 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.059 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.004 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 43.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007632
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -46,654 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 25.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -151.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 34.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -31.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 870,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -224,633 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -18.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -2.87M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 13.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -3.99M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap IncreaseDecreaseInDepositsOutstanding Increase (Decrease) in Deposits Outstanding USD 52,320 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -311,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 391,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD -146,635 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 10,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 254,900 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 564,804 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-281118
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 9.31M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 676,050 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-281118
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap InterestExpenseOther Interest Expense, Other USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 55,140 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap InvestmentIncomeNonoperating Investment Income, Nonoperating USD 5.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 36,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap LeaseCost Lease, Cost USD 367,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.106 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 846,825 2019-09-30 2019 Q3 10-Q 2019-11-07 0001558370-19-010290
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 107,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 223,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 156,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 353,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap Liabilities Liabilities USD 25.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 299.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LiabilitiesCurrent Liabilities, Current USD 23.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 207.90M 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 138.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.67M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-08 0001558370-17-003731
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -6.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -62,969 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-08 0001558370-17-003731
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -55.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -9.06M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-08 0001558370-17-003731
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -85.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -79.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -79.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 10,464 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-281118
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 7.58M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-04 0001558370-16-005254
us-gaap OperatingExpenses Operating Expenses USD 96.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -91.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeaseCost Operating Lease, Cost USD 324,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 100,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-31 0001628280-25-036839
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 400,000 2024-01-01 2024-12-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 724,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeasePayments Operating Lease, Payments USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 314,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 5.02M 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 989,502 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 906,669 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.07M 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.04M 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.01M 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 906,669 2017-12-31 2017 FY 10-K 2018-03-06 0001558370-18-001553
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 562,798 2016-03-31 2016 Q1 10-Q 2016-05-04 0001558370-16-005254
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 896,758 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001558370-19-001537
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 52,948 2024-06-30 2024 Q2 10-Q 2024-08-08 0001558370-24-011579
us-gaap OtherAssets Other Assets USD 154,176 2023-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap OtherAssetsCurrent Other Assets, Current USD 5.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 984,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OtherOperatingIncome Other Operating Income USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 234,696 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 78,762 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap PaymentsForRestructuring Payments for Restructuring USD 3.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 200,000 2016-03-28 2016 Q1 10-Q 2016-05-04 0001558370-16-005254
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 8.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 2,890 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 2,890 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 4.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 299,232 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 603,737 2023-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 11.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 178.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 280,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 4,898 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 18.49M 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 30,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2,336 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002222
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.34M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.64M 2023-09-30 2023 Q3 10-Q 2023-11-03 0001558370-23-017505
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 809,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 1.37M 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 71.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 660,802 2003-05-21 2014-03-31 2014 Q1 10-Q 2014-05-09 0001193125-14-192508
us-gaap RestrictedCash Restricted Cash USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 152.75M 2025-06-30 2025 Q2 10-Q 2025-07-31 0001628280-25-036839
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated employee 26 2024-07-01 2024-07-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.8 2024-07-01 2024-07-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap RestructuringCharges Restructuring Charges USD 7.00M 2024-01-01 2024-12-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 7.53M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap RestructuringReserveAcceleratedDepreciation Restructuring and Related Cost, Accelerated Depreciation USD 400,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -257.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 10,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap Revenues Revenues USD 20.00M 2015-06-01 2015-06-30 2018 Q3 10-Q 2018-11-02 0001558370-18-008314
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 19.70M 2016-06-01 2016-06-30 2016 FY 10-K 2017-03-01 0001558370-17-001198
us-gaap SecurityDeposit Security Deposit USD 52,320 2016-05-31 2024 Q1 10-Q 2024-05-09 0001558370-24-007632
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 6.60M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093802
us-gaap SeveranceCosts1 Severance Costs USD 7.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001558370-25-000948
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001558370-15-002591
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001558370-15-002591
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001558370-15-002591
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001558370-15-002591
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 48,133 2024-12-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 3.81 2024-12-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 48,133 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 3.81 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.904 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 3.00M 2022-01-01 2022-01-31 2022 Q1 10-Q 2022-04-28 0001558370-22-006260
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 11.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.99 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 77,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 118,804 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 13.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 3.32M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 687,164 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 13.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 28.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.51 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 28.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 10.51 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 140,683 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001558370-16-003688
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 10.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.15 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap SharePrice Share Price USD/shares 25.92 2006-10-13 2014 Q2 10-Q 2014-07-31 0001193125-14-289579
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 6.1 2016-06-30 2016 FY 10-K 2017-03-01 0001558370-17-001198
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 43,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 274.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.01 2025-06-13 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.48M 2016-06-01 2016-06-30 2016 FY 10-K 2017-03-01 0001558370-17-001198
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 8,174 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 280,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 36,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11.01M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 33,768 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-03 0001558370-23-007744
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 61,616 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0001558370-24-015537
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 89,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 2.24M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001558370-16-009291
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 177,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD -6.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted USD -6.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001628280-26-073389
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 44.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-011983
us-gaap VariableLeaseCost Variable Lease, Cost USD 29,812 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 64.52M 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 51.27M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0001558370-21-014003
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 64.52M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001558370-25-007780

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →